¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Free Form Amino Acid Complex Oral"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • free radical
    ÀÚÀ¯¶óµðÄ®, ÀÚÀ¯±â
  • free receptor
    À¯¸®¼ö¿ëü
  • free scolex
    À¯¸®µÎÀý
  • free surface
    ÀÚÀ¯¸é
  • free villus
    ÀÚÀ¯À¶¸ð
  • free water
    À¯¸®¼ö, ÀÚÀ¯¼ö
  • free water clearance
    À¯¸®¼öºÐÁ¦°Å, À¯¸®¼öºÐÁ¦°ÅÀ²
  • free water proton
    ÀÚÀ¯¹°¾ç¼ºÀÚ, ÀÚÀ¯¼öºÐ¾ç¼ºÀÚ
  • free-air chamber
    ÀÚÀ¯°ø±âÇÔ
  • free-floating anxiety
    ¸·¿¬ÇѺҾÈ, ºÎµ¿¼ººÒ¾È
  • free-living ameba
    ÀÚÀ¯»ýȰ¾Æ¸Þ¹Ù
  • free-living cycle
    ÀÚÀ¯»ýȰ°í¸®
  • free-living generation
    ÀÚÀ¯»ýȰ¼¼´ë
  • free-running
    ¹«µ¿Á¶
  • germ-free
    ¹«±Õ-
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • organic acid
    À¯±â»ê
  • oxalic acid
    ¿Á»ì»ê
  • propionic acid
    ÇÁ·ÎÇǿ»ê
  • pyruvic acid
    ÇÇ·çºê»ê
  • retinoic acid
    ·¹Æ¼³ë»ê, ·¹Æ¼³ëÀλê
  • ribonucleic acid
    ¸®º¸ÇÙ»ê, ¾Ë¿£¿¡ÀÌ
  • saturated fatty acid
    Æ÷È­Áö¹æ»ê
  • succinic acid
    ¼÷½Å»ê
  • sulfuric acid
    Ȳ»ê
  • unsaturated fatty acid
    ºÒÆ÷È­Áö¹æ»ê
  • uric acid
    ¿ä»ê
  • valproic acid
    ¹ßÇÁ·ÎÀÌÅ©»ê
  • vanillylmandelic acid
    ¹Ù´Ò¸¸µ¨»ê
  • gamma aminobutyric acid
    °¨¸¶¾Æ¹Ì³ëºÎƼ¸£»ê
  • acid burn
    »êÈ­»ó
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • drug-induced immune complex
    ¾àÁ¦À¯¹ß¸é¿ªº¹ÇÕü
  • ego-alien complex
    ÀÚ¾ÆÀÌÁúÄÄÇ÷º½º
  • ethmomaxillary complex
    ¹úÁýÀ§ÅλÀº¹ÇÕü, »ç°ñ»ó¾Çº¹ÇÕü
  • exstrophy-epispadias complex
    ¹æ±¤¹øÁü¿äµµÀ§¿­¸²º¹ÇÕü
  • father complex
    ¾Æ¹öÁöÄÞÇ÷º½º
  • Golgi¡¯s complex
    °ñÁöº¹ÇÕü
  • human leukocyte antigen complex
    »ç¶÷¹éÇ÷±¸Ç׿øº¹ÇÕü
  • immune complex
    ¸é¿ªº¹ÇÕü
  • inferiority complex
    ¿­µîÄÞÇ÷º½º, ¿­µî°¨
  • junctional complex
    ¿¬Á¢º¹ÇÕü
  • major histocompatibility complex
    ÁÖÁ¶Á÷ÀûÇÕº¹ÇÕü
  • Merkel cell-neurite complex
    Ã˰¢¼¼Æ÷½Å°æµ¹±âº¹ÇÕü
  • minor histocompatibility complex
    ºÎÁ¶Á÷ÀûÇÕº¹ÇÕü
  • mother complex
    ¾î¸Ó´ÏÄÞÇ÷º½º
  • mother-infant complex
    ¸ðÀÚÄÞÇÁ·º½º
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • Electra complex
    ¿¤·ºÆ®¶óÄÞÇ÷º½º
  • Ghon s complex
    °ïº´º¯±º.
  • Ghon s complex
    °ïº´º¯±º
  • Ghon s primary complex
    °ï¿ø¹ßÁõÈıº.
  • Ghons complex
    °ïº´º¯±º.
  • Golgi s complex
    °ñÁöÀåÄ¡, °ñÁöº¹ÇÕü.
  • HLA complex
    HLAÀ¯ÀüÀÚ±Õ.
  • HLA complex
    HLAÀ¯ÀüÀÚ±Õ.
  • Immune complex
    ¸é¿ªº¹ÇÕü(Øóæ¹ÜÜùêô÷)
  • Lutembacher s complex
    ·òÅÁ¹Ù½¬¿¡ÁõÈıº.
  • MHC => major histocompatibility complex
    ÁÖÁ¶Á÷ÀûÇÕº¹ÇÕü
  • Oedipism=Oedipus complex
    ¿¡µðǪ½º ÄÞÇ÷º½º
  • Oedipus complex
    ¿¡µðǪ½º ÄÞÇ÷º½º.
  • activated complex
    Ȱ¼ºº¹ÇÕ, Ȱ¼ºº¹ÇÕ¹°
  • acyl-plasminogen streptokinase activator complex
    ¾Æ½Ç-Çø®Áî¹Ì³ë°Õ½ºÆ®·¾ÅäŰ³ªÁ¦È°¼ºÁ¦º¹ÇÕü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • consent form
    µ¿ÀǼ­ Çü½Ä(ÔÒëòßö úýãÒ)
  • corrosion form
    ºÎ½ÄÇü(ݯãÚúþ).
  • crescent form
    ¹Ý´ÞÇü, ¹Ý¿ùü, ¹Ý¿ùÇü.
  • developmental form
    ¹ß´ÞÇü.
  • developmental form
    ¹ßÀ°Çü
  • distal form
    ¸»´ÜÇü(ØÇÓ®úþ).
  • enol form
    ¿¡³îÇü(¡­û¡).
  • erythrocytic form
    Àû³»Çü.[³»°ú](Àû)Ç÷±¸(³»)Çü.
  • filamentous form
    ¼±Çü, ½Ç¸ð¾ç
  • filamentous form
    ¼±Çü, ½Ç¸ð¾ç
  • filt(e)rable form
    ¿©°úÇü
  • filterable form
    ¿©°úÇü
  • form of ovum
    ³­ÀÚÇü
  • form vision
    ÇüŽÃ
  • fried egg form
    °è¶õºÎÄ¡°³¸ð¾ç
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • amino acid composition
    ¾Æ¹Ì³ë»ê Á¶¼º(ðÚà÷)
  • amino acid incorporation
    ¾Æ¹Ì³ë»ê(ß«) ÆíÀÔ(øºìý)
  • amino acid nitrogen
    ¾Æ¹Ì³ë»ê(ß«) Áú¼Ò(òòáÈ)
  • amino acid oxidase
    ¾Æ¹Ì³ë»ê(ß«) ¿Á½Ãµ¥À̽º
  • amino acid replacement
    ¾Æ¹Ì³ë»ê(ß«) ´ëü(ÓÛôð)
  • amino acid residue
    ¾Æ¹Ì³ë»ê(ß«) Àܱâ(íÑÐñ)
  • amino acid sequence
    ¾Æ¹Ì³ë»ê(ß«) ¼­¿­(ßíæê)
  • amino acid sequencer
    ¾Æ¹Ì³ë»ê(ß«) ¼­¿­°áÁ¤±â(ßíæê̽ïÒÐï)
  • amino acid side chain
    ¾Æ¹Ì³ë»ê(ß«) °ç»ç½½
  • amino acid starvation
    ¾Æ¹Ì³ë»ê(ß«) ±â¾Æ(ÑÆä»)
  • amino acid substitution
    ¾Æ¹Ì³ë»ê ġȯ(öÇüµ)
  • aromatic amino acid
    ¹æÇâÁ·(Û»úÅðé) ¾Æ¹Ì³ë»ê(ß«)
  • basic amino acid
    ¿°±â¼º(ç¤Ðñàõ) ¾Æ¹Ì³ë»ê(ß«)
  • tert-BOC-amino acid
    Å͸£Æ®-BOC-¾Æ¹Ì³ë»ê(ß«)
  • CBZ-amino acid
    (å²) carbobenzoxy-¾Æ¹Ì³ë»ê(ß«)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • free surface
    ÀÚÀ¯¸é
  • free water in stationary tissue
    Á¤ÀûÁ¶Á÷³» ÀÚÀ¯¼öºÐ
  • free water proton
    ÀÚÀ¯¼öºÐ¾ç¼ºÀÚ
  • free zone
    ÀÚÀ¯¿µ¿ª, ºó¿µ¿ª
  • free-flowing effusion
    ÀÚÀ¯À¯µ¿»ïÃâ¾×
  • free-hand technique
    ¼Õ±â¹ý
  • oxidative free radical
    »êÈ­ÀÚÀ¯±â
  • oxygen free radical
    »ê¼ÒÀÚÀ¯±â
  • salt-free diet
    ¹«¿°½Ä(ÀÌ)
  • SSFP [=steady state free precession]
    Ç×Á¤»óÅÂÀÚÀ¯¼¼Â÷
  • steady state free precession [=SSFP]
    Ç×Á¤»óÅÂÀÚÀ¯¼¼Â÷
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
PAS   1) Periodic Acid-Schiff Stain
  2) Para-Amino-Salicyclic Acid
 &nbs...
Asx amino acid that gives aspartic acid after hydrolysis; asymptomatic
APSAC   1) Acylating the Plasminogen Streptokinase Activated Complex
  2) Anisoylat...
APSAC acylated plasminogen-streptokinase activator complex; anisoylated plasminogen streptokinase activato...
ARC accelerating rate calorimetry; acquired immunodeficiency syndrome-related complex; active renin conc...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
SF-36 Short Form 36-Item
SF-36 Short Form Health Survey
SHSS:C Standford Hypnotic Susceptibility Scale, Form C
TRF Teacher Report Form
CRF circulating recombinant form
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • joint of free upper limb
    ÀÚÀ¯ »óÁö ¿¬°á
  • K free diet
    K °áÇÌ À½½Ä
  • salt-free diet
    ¹«¿°½Ä, ¹«¿° ½ÄÀÌ
  • steady state free precession
    Ç×Á¤ »óÅ ÀÚÀ¯ ¼¼Â÷
  • abortive form
    ºÎÀüÇü
  • abrupt form
    ±ÞÃßÇü
  • allotropic form
    µ¿¼Òü
  • alveolar ridge running in concave form
    ¿ä¸¸Çü Ä¡Á¶¿¬
  • anatomic form
    ÇØºÎÇÐÀû ÇüÅÂ
  • anterior tooth form
    ÀüÄ¡ºÎ Ä¡Çü
  • atrophic form
    À§Ãà ÇüÅÂ
  • auxiliary retention form
    º¸Á¶Àû À¯Áö ÇüÅÂ
  • balanced form
    ±ÕÇüÇü
  • band form
    ´ë»óü, °£»ó, °£»ó ¼¼Æ÷, ´ë»óÇü
  • box-form
    »óÇü ¿Íµ¿ÀÇ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
excitatory amino acid agonists Drugs that bind to and activate excitatory amino acid receptors.
(12 Dec 1998)
excitatory amino acid antagonists Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists.
(12 Dec 1998)
1-carbamoyl-L-amino acid amidohydrolase <enzyme> From bacillus stearothermophilus; amino acid sequence given in first source
Registry number: EC 3.5.1.-
Synonym: carbamoyl l-aa amidohydrolase, n-carbamyl-l-amino acid amidohydrolase
(26 Jun 1999)
alpha-keto acid dehydrogenase complex See: alpha-keto acid dehydrogenase.
Anaerobic dehydrogenase, an enzyme (usually a pyridinoenzyme) catalyzing the transfer of hydrogen from some metabolite to some acceptor molecule (e.g., NAD+, cytochrome) other than oxygen; e.g., lactate dehydrogenase's, isocitrate dehydrogenase's, and others in EC class 1, excluding those listed under aerobic dehydrogenase.
(05 Mar 2000)
fatty acid synthase complex The multienzyme complex that catalyses the formation of palmitate from acetylcoenzyme A, malonylcoenzyme A, and NADPH.
(05 Mar 2000)
fatty acid synthetase complex <enzyme> Registry number: EC 6.-
(12 Dec 1998)
a-form DNA <molecular biology> One of several forms that can be assumed by a double helix. A-DNA is stable in dehydrated conditions.
This form is less common than the dominant form found under physiological conditions -- beta-DNA. This form is also assumed by DNA-RNA hybrid helices and by regions of double-stranded RNA. It is a right-handed helix and is a more compact form than beta-DNA.
(09 Oct 1997)
boat form The less stable of two conformations assumed by 6-membered cyclic sugars (pyranoses) or cyclohexane derivatives, as opposed to chair form.
See: Haworth conformational formulas of cyclic sugars.
(05 Mar 2000)
cavity preparation form The configuration or shape of a cavity preparation.
(05 Mar 2000)
replicative form An intermediate stage in the replication of either DNA or RNA viral genomes that is usually double stranded, the altered, double-stranded form to which single-stranded coliphage DNA is converted after infection of a susceptible bacterium, formation of the complementary ("minus") strand being mediated by enzymes that were present in the bacterium before entrance of the viral ("plus") strand.
(05 Mar 2000)
resistance form The shape given to a cavity preparation that enables the dental restoration to withstand masticatory forces.
(05 Mar 2000)
retention form The shape of a cavity preparation that prevents displacement of the dental restoration by lateral or tipping forces as well as masticatory forces.
(05 Mar 2000)
chair form The more stable of two conformations assumed by 6-membered cyclic sugars (e.g., the pyranoses) or cyclohexane derivatives, as opposed to boat form.
See: Haworth conformational formulas of cyclic sugars.
(05 Mar 2000)
wave form The form of a pulse; e.g., an arterial pressure or displacement wave; or of the pacemaker pulse as demonstrated on the oscilloscope under a specified load.
Synonym: waveshape.
(05 Mar 2000)
wax form A pattern of wax that, when invested and burned out or otherwise eliminated, will produce a mold in which a casting may be made.
Synonym: wax form.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • citric acid
    ±¸¿¬»ê
  • acetic acid
    ÃÊ»ê
  • acetylsalicylic acid
    =ASPIRIN
  • acid
    »ê;½Å¸À(ÀÌ ÀÖ´Â);½Å;½Å¶öÇÑ;ºÎ·çÅüÇÑ
  • acid test
    »ê½ÃÇè;¾ö¹ÐÇѽÃÇè
  • acid trip
    LSD¿¡ÀÇÇÑ È¯°¢Ã¼Çè
  • acrylic acid
    ¾ÆÅ©¸±»ê
  • aminobenzoic acid
    ¾Æ¹Ì³ë¾È½ÄÇâ»ê
  • arsenious acid
    ¾Æºñ»ê
  • ascorbic acid
    ¾Æ½ºÄÚ¸£ºó»ê(ºñŸ¹Î cÀÇ º°¸í)
  • barbituric acid
    ¹Ù¸£ºñÅõ¸£»ê
  • butyric acid
    ³«»ê
  • capric acid
    Ä«ÇÁ¸£»ê
  • caproic acid
    Ä«ÇÁ·Î»ê
  • carbolic acid
    ¼®Åº»ê
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á